[1] |
Cowman S, van Ingen J, Griffith DE, et al. Non-tuberculous mycobacterial pulmonary disease. Eur Respir J, 2019, 54(1):1900250. doi:10.1183/13993003.00250-2019.
|
[2] |
Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clin Infect Dis, 2020, 71(4): e1-e36. doi:10.1093/cid/ciaa241.
|
[3] |
Nessar R, Cambau E, Reyrat JM, et al. Mycobacterium abscessus: a new antibiotic nightmare. J Antimicrob Chemother, 2012, 67(4): 810-818. doi:10.1093/jac/dkr578.
pmid: 22290346
|
[4] |
Andries K, Verhasselt P, Guillemont J, et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science, 2005, 307(5707): 223-227. doi:10.1126/science.1106753.
pmid: 15591164
|
[5] |
World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: World Health Organization, 2019.
|
[6] |
Ruth MM, Sangen JJN, Remmers K, et al. A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria. Antimicrob Chemother, 2019, 74(4): 935-943. doi:10.1093/jac/dky526.
|
[7] |
Pym AS, Diacon AH, Tang SJ, et al. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis. Eur Respir J, 2016, 47(2): 564-574. doi:10.1183/13993003.00724-2015.
pmid: 26647431
|
[8] |
Brown-Elliott BA, Wallace RJ Jr. In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium abscessus Complex. Antimicrob Agents Chemother, 2019, 63(2): e01919-18. doi:10.1128/AAC.01919-18.
|
[9] |
Gao M, Gao J, Xie L, et al. Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study. Clin Microbiol Infect, 2021, 27(4): 597-602. doi:10.1016/j.cmi.2020.06.004.
|
[10] |
Huang Z, Luo W, Xu D, et al. Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent. Bioorg Med Chem Lett, 2022, 71: 128824. doi:10.1016/j.bmcl.2022.128824.
|
[11] |
Yao R, Wang B, Fu L, et al. Sudapyridine (WX-081), a Novel Compound against Mycobacterium tuberculosis. Microbiol Spectr, 2022, 10(1): e0247721. doi:10.1128/spectrum.02477-21.
|
[12] |
Zhu R, Shang Y, Chen S, et al. In Vitro Activity of the Sudapyridine (WX-081) against Non-Tuberculous Mycobacteria Isolated in Beijing, China. Microbiol Spectr, 2022, 10(6): e0137222. doi:10.1128/spectrum.01372-22.
|
[13] |
van der Sar AM, Appelmelk BJ, Vandenbroucke-Grauls CM, et al. A star with stripes: zebrafish as an infection model. Trends Microbiol, 2004, 12(10): 451-457. doi:10.1016/j.tim.2004.08.001.
pmid: 15381194
|
[14] |
Dupont C, Viljoen A, Thomas S, et al. Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish. Antimicrob Agents Chemother, 2017, 61(11): e01225-17. doi:10.1128/AAC.01225-17.
|
[15] |
Winters CG, Basnet RM, Faasuamalie PE, et al. Disulfiram Is Effective against Drug-Resistant Mycobacterium abscessus in a Zebrafish Embryo Infection Model. Antimicrob Agents Chemother, 2022, 66(11): e0053922. doi:10.1128/aac.00539-22.
|
[16] |
Lefebvre AL, Le Moigne V, Bernut A, et al. Inhibition of the β-Lactamase BlaMab by Avibactam Improves the In Vitro and In Vivo Efficacy of Imipenem against Mycobacterium abscessus. Antimicrob Agents Chemother, 2017, 61(4): e02440-16. doi:10.1128/AAC.02440-16.
|
[17] |
Bernut A, Le Moigne V, Lesne T, et al. In vivo assessment of drug efficacy against Mycobacterium abscessus using the embryonic zebrafish test system. Antimicrob Agents Chemother, 2014, 58(7): 4054-4063. doi:10.1128/AAC.00142-14.
|
[18] |
Upton CM, Steele CI, Maartens G, et al. Pharmacokinetics of bedaquiline in cerebrospinal fluid (CSF) in patients with pulmonary tuberculosis (TB). J Antimicrob Chemother, 2022, 77(6): 1720-1724. doi:10.1093/jac/dkac067.
pmid: 35257182
|
[19] |
Quiñonez-Silvero C, Hübner K, Herzog W. Development of the brain vasculature and the blood-brain barrier in zebrafish. Dev Biol, 2020, 457(2):181-190. doi:10.1016/j.ydbio.2019.03.005.
pmid: 30862465
|